BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9406551)

  • 1. Structural characterization of activation 'intermediate 2' on the pathway to human gastricsin.
    Khan AR; Cherney MM; Tarasova NI; James MN
    Nat Struct Biol; 1997 Dec; 4(12):1010-5. PubMed ID: 9406551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of activation of the gastric aspartic proteinases: pepsinogen, progastricsin and prochymosin.
    Richter C; Tanaka T; Yada RY
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):481-90. PubMed ID: 9794784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural aspects of activation pathways of aspartic protease zymogens and viral 3C protease precursors.
    Khan AR; Khazanovich-Bernstein N; Bergmann EM; James MN
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):10968-75. PubMed ID: 10500110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human progastricsin. Analysis of intermediates during activation into gastricsin and determination of the amino acid sequence of the propart.
    Foltmann B; Jensen AL
    Eur J Biochem; 1982 Nov; 128(1):63-70. PubMed ID: 6816595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic studies of an activation intermediate of human gastricsin.
    Khan AR; Chernaia MM; Tarasova NI; James MN
    Adv Exp Med Biol; 1998; 436():265-70. PubMed ID: 9561229
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification and characterization of porcine pepsinogen B and pepsin B.
    Nielsen PK; Foltmann B
    Arch Biochem Biophys; 1995 Oct; 322(2):417-22. PubMed ID: 7574716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refined structure of porcine pepsinogen at 1.8 A resolution.
    Sielecki AR; Fujinaga M; Read RJ; James MN
    J Mol Biol; 1991 Jun; 219(4):671-92. PubMed ID: 2056534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal portion acts as an initiator of the inactivation of pepsin at neutral pH.
    Tanaka T; Yada RY
    Protein Eng; 2001 Sep; 14(9):669-74. PubMed ID: 11707613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal and molecular structures of human progastricsin at 1.62 A resolution.
    Moore SA; Sielecki AR; Chernaia MM; Tarasova NI; James MN
    J Mol Biol; 1995 Mar; 247(3):466-85. PubMed ID: 7714902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of an activation intermediate of cathepsin E.
    Ostermann N; Gerhartz B; Worpenberg S; Trappe J; Eder J
    J Mol Biol; 2004 Sep; 342(3):889-99. PubMed ID: 15342244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional chimera of porcine pepsin prosegment and Plasmodium falciparum plasmepsin II.
    Parr-Vasquez CL; Yada RY
    Protein Eng Des Sel; 2010 Jan; 23(1):19-26. PubMed ID: 19910416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the mechanism of prosegment-catalyzed folding by solution NMR spectroscopy.
    Wang S; Horimoto Y; Dee DR; Yada RY
    J Biol Chem; 2014 Jan; 289(2):697-707. PubMed ID: 24265313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of porcine pepsinogen A and progastricsin. Sequencing of the first 73 amino acid residues in progastricsin.
    Foltmann B; Drøhse HB; Nielsen PK; James MN
    Biochim Biophys Acta; 1992 May; 1121(1-2):75-82. PubMed ID: 1599954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the activation of P. vivax plasmepsin.
    Bernstein NK; Cherney MM; Yowell CA; Dame JB; James MN
    J Mol Biol; 2003 Jun; 329(3):505-24. PubMed ID: 12767832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.
    Khan AR; James MN
    Protein Sci; 1998 Apr; 7(4):815-36. PubMed ID: 9568890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from plasmodium falciparum.
    Bernstein NK; Cherney MM; Loetscher H; Ridley RG; James MN
    Nat Struct Biol; 1999 Jan; 6(1):32-7. PubMed ID: 9886289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus.
    Newman M; Watson F; Roychowdhury P; Jones H; Badasso M; Cleasby A; Wood SP; Tickle IJ; Blundell TL
    J Mol Biol; 1993 Mar; 230(1):260-83. PubMed ID: 8450540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pepstatin inhibition studies on individual human pepsins and pepsinogens 1,3 and 5(gastricsin) and pig pepsin A.
    Roberts NB; Taylor WH
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):209-17. PubMed ID: 14506911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation.
    Gomis-Rüth FX; Gómez-Ortiz M; Vendrell J; Ventura S; Bode W; Huber R; Avilés FX
    J Mol Biol; 1997 Jun; 269(5):861-80. PubMed ID: 9223647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous pepsin C-catalyzed activation of human pepsinogen C in transgenic rice cell suspension culture: Production and characterization of human pepsin C.
    Islam MR; Kim NS; Jung JW; Kim HB; Han SC; Yang MS
    Enzyme Microb Technol; 2018 Jan; 108():66-73. PubMed ID: 29108629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.